The T-cell-inflamed tumor microenvironment as a paradigm for immunotherapy drug development

被引：14

作者：

Olson, Daniel J. ^{[1
]}

Luke, Jason J. ^{[1
]}

机构：

[1] Univ Chicago, Dept Med, Sect Hematol Oncol, 5841 South Maryland Ave,MC 2115, Chicago, IL 60637 USA

来源：

IMMUNOTHERAPY | 2019年 / 11卷 / 03期

关键词：

cancer immunology; checkpoint inhibitors; clinical immunology; clinical trial design; immunotherapy; CANCER; PEMBROLIZUMAB; RADIOTHERAPY;

D O I：

10.2217/imt-2018-0171

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：155 / 159

页数：5

共 21 条

[1] Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice [J].

Amos, Sally M. ;

Pegram, Hollie J. ;

Westwood, Jennifer A. ;

John, Liza B. ;

Devaud, Christel ;

Clarke, Chris J. ;

Restifo, Nicholas P. ;

Smyth, Mark J. ;

Darcy, Phillip K. ;

Kershaw, Michael H. .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (05) :671-683

[2] Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma [J].

Andtbacka, Robert H. I. ;

Kaufman, Howard L. ;

Collichio, Frances ;

Amatruda, Thomas ;

Senzer, Neil ;

Chesney, Jason ;

Delman, Keith A. ;

Spitler, Lynn E. ;

Puzanov, Igor ;

Agarwala, Sanjiv S. ;

Milhem, Mohammed ;

Cranmer, Lee ;

Curti, Brendan ;

Lewis, Karl ;

Ross, Merrick ;

Guthrie, Troy ;

Linette, Gerald P. ;

Daniels, Gregory A. ;

Harrington, Kevin ;

Middleton, Mark R. ;

Miller, Wilson H., Jr. ;

Zager, Jonathan S. ;

Ye, Yining ;

Yao, Bin ;

Li, Ai ;

Doleman, Susan ;

VanderWalde, Ari ;

Gansert, Jennifer ;

Coffin, Robert S. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (25) :2780-U98

[3]

Ascierto P.A., 2017, Initial efficacy of anti-lymphocyte activation gene-3 (anti-LAG-3

[4]

BMS-986016) in combination with nivolumab (nivo) in pts with melanoma (MEL) previously treated with anti-PD-1/PD-L1 therapy

[5] IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade [J].

Ayers, Mark ;

Lunceford, Jared ;

Nebozhyn, Michael ;

Murphy, Erin ;

Loboda, Andrey ;

Kaufman, David R. ;

Albright, Andrew ;

Cheng, Jonathan D. ;

Kang, S. Peter ;

Shankaran, Veena ;

Piha-Paul, Sarina A. ;

Yearley, Jennifer ;

Seiwert, Tanguy Y. ;

Ribas, Antoni ;

McClanahan, Terrill K. .

JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (08) :2930-2940

[6] The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon-Dependent Innate and Adaptive Immunity [J].

Burnette, Byron C. ;

Liang, Hua ;

Lee, Youjin ;

Chlewicki, Lukasz ;

Khodarev, Nikolai N. ;

Weichselbaum, Ralph R. ;

Fu, Yang-Xin ;

Auh, Sogyong L. .

CANCER RESEARCH, 2011, 71 (07) :2488-2496

[7] The host STING pathway at the interface of cancer and immunity [J].

Corrales, Leticia ;

McWhirter, Sarah M. ;

Dubensky, Thomas W., Jr. ;

Gajewski, Thomas F. .

JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (07) :2404-2411

[8]

Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x

[9] LAG-3 regulates CD8+T cell accumulation and effector function in murine self- and tumor-tolerance systems [J].

Grosso, Joseph F. ;

Kelleher, Cristin C. ;

Harris, Timothy J. ;

Maris, Charles H. ;

Hipkiss, Edward L. ;

De Marzo, Angelo ;

Anders, Robert ;

Netto, George ;

Getnet, Derese ;

Bruno, Tullia C. ;

Goldberg, Monica V. ;

Pardoll, Drew M. ;

Drake, Charles G. .

JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (11) :3383-3392

[10] Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment [J].

Harlin, Helena ;

Meng, Yuru ;

Peterson, Amy C. ;

Zha, Yuanyuan ;

Tretiakova, Maria ;

Slingluff, Craig ;

McKee, Mark ;

Gajewski, Thomas F. .

CANCER RESEARCH, 2009, 69 (07) :3077-3085

← 1 2 3 →